Table 4.

Comorbidities that may benefit from cardio-oncology clinic referral

Condition	Additional treatment that may be indicated
Heart failure or impaired LV or RV function	Diuresis LV enhancement therapy (β blocker, ACE/ARB/ ARNI, MRA, ivabradine) Device therapy as per CCS HF guidelines
Atrial fibrillation/flutter	Stroke prevention therapy as per CCS AF guidelines Rate or rhythm control (including ablation)
Uncontrolled hypertension	Antihypertensive therapy as per Canadian Hypertension Education Program (CHEP) guidelines
Uncontrolled diabetes	Anti-hyperglycemic therapy as per Diabetes Canada (DC) guidelines

ACE: angiotensin-converting enzyme; AF: atrial fibrillation; ARB: angiotensin II receptor blocker; ARNI: angiotensin receptor II blocker - neprilysin inhibitor; CCS: Canadian Cardiovascular Society; HF: heart failure; LV: left ventricular; MRA: magnetic resonance angiogram; RV: right ventricular.